Vivalytic VRI Multiplex Test
Viral respiratory infections (VRI) can cause serious respiratory diseases and even spread unnoticed under certain circumstances. Many of them lead to similar symptoms, which often hinders a quick diagnosis. This is exactly where the Vivalytic VRI test comes in.
This multiplex assay tests the patient sample for the SARS-CoV‑2 virus as well as for other relevant viral respiratory tract infections with similar symptoms. With the Vivalytic VRI test, doctors can quickly and efficiently differentiate between the various infections, such as the different types of influenza, and immediately initiate the right treatment.
The test delivers a reliable result in less than 2.5 hours according to WHO guidelines at the point-of-care, i.e. in the immediate vicinity of the patient’s sample collection. A time-consuming logistics chain, where the samples have to be transported, is therefore not necessary.
Respiratory infections
- Human adenovirus A/B/C/D/E
- Human coronavirus 229E/NL63
- Human coronavirus OC43/HKU1
- Human enterovirus A/B/C/D
- Human rhinovirus A/B/C
- Influenza A virus
- Influenza B virus
- MERS coronavirus (MERS-CoV)
- Sarbecovirus (SARS-CoV, SARS-like CoV, SARS-CoV‑2
- SARS coronavirus 2 (SARS-CoV‑2)
Product Specifications
|
Sample Type |
Nasopharyngeal and/or oropharyngeal swab |
|---|---|
|
Sample Input Volume |
300µl |
|
Reagent Storage Conditions |
15 – 25 °C |
|
|
|
Ordering Information
|
Product |
Pack size |
Order number |
|---|---|---|
|
Vivalytic VRI |
15 cartridges |
V2013 |